NASDAQ:KMTS Kestra Medical Technologies Q1 2026 Earnings Results & Report $27.09 +1.62 (+6.34%) As of 03:05 PM Eastern This is a fair market value price provided by Massive. Learn more. Kestra Medical Technologies beat analyst expectations on both earnings and revenue in its Q1 2026 results, released September 11, 2025. The company reported EPS of -$0.50 versus the -$0.66 consensus estimate, while revenue of $19.37 million topped the $17.68 million estimate by $1.69 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2026Report DateSeptember 11, 2025TimeAfter Market ClosesConference Call7:00 AM ET Kestra Medical Technologies EPS ResultsActual EPS-$0.50Consensus EPS -$0.66Beat/MissBeat by +$0.16One Year Ago EPSN/AEPS Beat Rate1 of last 6 quartersKestra Medical Technologies Revenue ResultsActual Revenue$19.37 millionExpected Revenue$17.68 millionBeat/MissBeat by +$1.69 millionYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile Kestra Medical Technologies Q1 2026 Earnings FAQ Did Kestra Medical Technologies beat earnings estimates for Q1 2026? Kestra Medical Technologies (NASDAQ:KMTS) reported earnings of -$0.50 per share for Q1 2026, beating the consensus estimate of -$0.66. The report was announced on Thursday, September 11, 2025. What was Kestra Medical Technologies' revenue for Q1 2026? Kestra Medical Technologies reported revenue of $19.37 million for Q1 2026, against a consensus estimate of $17.68 million. Kestra Medical Technologies Earnings HeadlinesKestra Medical Technologies Ltd KMTSOctober 14 at 2:32 PM | morningstar.comMKestra Medical Technologies Inc (KMTS)October 2, 2026 | in.investing.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.October 15 at 1:00 AM | Stansberry Research (Ad)Kestra Medical Technologies Ltd. (KMTS) Gets a Buy from BTIGOctober 2, 2026 | theglobeandmail.comKestra Medical Technologies Earns Five-Star Rating on Newsweek’s List of America’s Greatest Mid-Market CompaniesOctober 1, 2026 | markets.businessinsider.comKestra Medical Technologies Earns Five-Star Rating on Newsweek’s America’s Greatest Mid-Market Companies 2026 ListOctober 1, 2026 | quiverquant.comQSee More Kestra Medical Technologies Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Kestra Medical Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kestra Medical Technologies and other key companies, straight to your email. Email Address About Kestra Medical TechnologiesKestra Medical Technologies (NASDAQ:KMTS), Inc. is a medical device company focused on developing and commercializing technologies designed to help protect patients at risk of sudden cardiac arrest. The company’s primary product is the ASSURE wearable cardioverter defibrillator, or WCD, which is intended to provide temporary protection for patients who may be at elevated risk of life-threatening ventricular arrhythmias. The ASSURE system continuously monitors a patient’s heart rhythm and is designed to detect potentially dangerous arrhythmias, including ventricular tachycardia and ventricular fibrillation. When appropriate, the device can deliver a therapeutic shock to help restore a normal heart rhythm. Its wearable format is intended to support patients during periods when they are not yet candidates for, or are waiting to receive, a permanently implanted cardiac defibrillator. Kestra’s products combine wearable hardware, cardiac monitoring, automated arrhythmia detection and connectivity intended to support physicians and care teams. The company’s operations are focused primarily on the United States, where the ASSURE system has received regulatory clearance and is used in the management of patients at risk for sudden cardiac arrest.View Kestra Medical Technologies ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Apple Cut iPhone 18 Orders; What Does It Mean For Suppliers?Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But UpFastenal Flashes Bullish Signal as Uptrend Holds Despite Margin PressureASML Can’t Keep Up With AI Demand—Why That's a Good ThingCiti Stock Falls Despite Earnings Beat: What Investors Need to KnowDon’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could DeepenBig Banks Report Strong Earnings—So Why Are Shares Falling? Upcoming Earnings Truist Financial (10/16/2026)Travelers Companies (10/16/2026)HDFC Bank (10/17/2026)ICICI Bank (10/17/2026)America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
